OBJECTIVE To raise compliance in a general practice based colorectal cancer screening programme by the use of a simple health educational leaflet. DESIGN A randomised controlled trial of the leaflet's effect on completion of faecal occult blood tests. The leaflet explained the high frequency of colorectal cancer, the principles of screening, and addressed reasons for non-compliance. SETTING...

INTRODUCTION Colonoscopy workload for endoscopy services in Western countries is increasing markedly because of the implementation of faecal occult blood-based mass screening programmes against colorectal cancer (CRC). We therefore explored the possibility of using a combination of faecal tests to prioritize the access to colonoscopy with criteria other than symptoms and/or time of referral. ...

To develop a complete economic evaluation to identify which screening test for Colon and Rectal Cancer (CCR) is the most cost-effective beneficiaries of Instituto Mexicano del Seguro Social (IMSS). Methodology: A cost-effectiveness analysis was carried out from perspective health system in 2020, through Markov model with time horizon 10 years. The used five scenarios, simulation took into accou...

Abstract: Low-molecular-weight heparins (LMWHs) have proven to be effective in the prevention and treatment of thrombotic disorders, as well substitute for unfractionated heparin (UFH). LMWHs are a diverse collection medicines with different biochemical pharmacological characteristics, despite fact that they all antithrombotic actions. Medicine is administered into subcutaneous tissues these in...

Colorectal cancer, a clinically diverse disease, is a leading cause of cancer-related death worldwide. Application of novel molecular diagnostic tests, which are summarized in this article, may lead to an improved survival of colorectal cancer patients.  Distinction of these applications is based on the different molecular principles found in colorectal cancer (CRC). Strategies for molecular an...

background: colorectal cancer is one of the most common cancers and second leading cause of cancer deaths worldwide. every year nearly one million new cases of colorectal cancer are recognized around the world and nearly half of them lose their lives due to the disease. researches shown that in early diagnosis of this cancer 90% of patients can be treated. the fecal occult blood test (fobt) bec...

INTRODUCTION Colorectal cancer (CRC) is the second leading cause of cancer-related deaths, but currently available noninvasive screening programs have achieved only a modest decrease in mortality. MicroRNAs (miRNA) play an important role in a wide array of biological processes and are commonly dysregulated in neoplasia. We aimed to evaluate the feasibility of fecal miRNAs as biomarkers for colo...

Colorectal cancer is the second commonest cause of cancer death in the UK. An effective national screening programme is urgently required to reduce the substantial morbidity and mortality from the disease. The success of any screening programme will depend on the screening test detecting early Dukes's A carcinomas and adenomatous polyps. Prognosis is directly related to tumour staging and a pro...

Rhodococcus equi pneumonia with systemic dissemination is being reported increasingly in immunocompromised patients. This is the first case report of disseminated R equi infection with biopsy documented involvement of the large intestine. The patient was a 46 year old male with AIDS who was diagnosed with cavitating pneumonia involving the left lower lobe. R equi was isolated in culture from th...

A 50-year old Malay female presented with a painless upper abdominal mass of three years duration. She was feeling anorexic and lethargic for about six months. There was no history of vomiting and colonic symptoms were absent. Examination revealed a thin anaemic lady with an intraabdominal mass of 5 x 7.5 ems., to the right of midline around the transpyloric plane. It was mobile in the oblique ...